Loading chat...
NJ A913
Bill
Status
1/12/2026
Primary Sponsor
Verlina Reynolds-Jackson
Click for details
AI Summary
-
Adds sickle cell anemia to the list of qualifying medical conditions for medical cannabis use in New Jersey
-
Amends the Jake Honig Compassionate Use Medical Cannabis Act (P.L.2009, c.307) to include this condition
-
Allows patients with sickle cell anemia to register with the Cannabis Regulatory Commission to obtain medical cannabis from licensed dispensaries
-
Sickle cell anemia is an inherited blood disorder characterized by chronic anemia and periodic episodes of pain, which cannabis may help alleviate
-
Takes effect immediately upon enactment
Legislative Description
Authorizes medical cannabis for treatment of sickle cell anemia.
Bills and Joint Resolutions Signed by the Governor
Last Action
Approved P.L.2025, c.223.
1/12/2026